OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 701 - 710 of 796 studies

Risk Stratification of Interstitial Lung Abnormalities using Hyperpolarised Xenon MRI and blood biomarkers

MyeloFiT: Myeloproliferative Neoplasms – Imaging-based assessment of Fibrosis and Thrombosis Risk (MyeloFiT)

Oxford Genetic Frontotemporal Dementia Initiative 3 (GENFI)

Interrogating immune- tumour interactions within the central nervous system

A phase 1 study to assess the safety and immunogenicity of R21/Matrix-MTM administered in an escalating dose, multi-prime vaccination schedule in healthy adults (VAC096)

A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Neurological

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (XPF-010-303)

Cancer and neoplasms

An Open-Label, 2-Arm, Multicenter, Randomized Phase 3 Study To Evaluate The Efficacy And Safety of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dexamethasone in Transplant-Ineligible Participants With Newly Diagnosed Multiple Myeloma (MagnetisMM6)

Metabolic and Endocrine

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia

A study of neuro-immune mechanisms in brain health from bio-samples (ANIMATE)